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STUDY PROTOCOL Open Access
The OPERA trial: protocol for a randomised trial
of an exercise intervention for older people in
residential and nursing accommodation
Martin Underwood1*, Sandra Eldridge2, Sallie Lamb1, Rachel Potter1, Bartley Sheehan1, Anne-Marie Slowther1,
Stephanie Taylor2, Margaret Thorogood1, Scott Weich1
Abstract
Background: Depression is common in residents of Residential and Nursing homes (RNHs). It is usually undetected
and often undertreated. Depression is associated with poor outcomes including increased morbidity and mortality.
Exercise has potential to improve depression, and has been shown in existing trials to improve outcomes among
younger and older people. Existing evidence comes from trials that are short, underpowered and not from RNH
settings. The aim of the OPERA trial is to establish whether exercise is effective in reducing the prevalence of
depression among older RNH residents.
Method: OPERA is a cluster randomised controlled trial. RNHs are randomised to one of two groups with
interventions lasting 12 months
Intervention group: a depression awareness and physical activity training session for care home staff, plus a
whole home physical activation programme including twice weekly physiotherapist-led exercise groups. The
intervention lasts for one year from randomisation, or
Control group: a depression awareness training session for care home staff.
Participants are people aged 65 or over who are free of severe cognitive impairment and willing to participate in
the study. Our primary outcome is the prevalence of depressive symptoms, a GDS-15 score of five or more, in all
participants at the end of the one year intervention period. Our secondary depression outcomes include remission
of depressive symptoms and change in GDS-15 scores in those with depressive symptoms prior to randomisation.
Other secondary outcomes include, fear of falling, mobility, fractures, pain, cognition, costs and health related
quality of life. We aimed to randomise 77 RNHs.
Discussion: Home recruitment was completed in May 2010; 78 homes have been randomised. Follow up will
finish in May 2011 and results will be available late 2011.
Trial Registration: [ISRCTN: ISRCTN43769277]
Background
Untreated depression is one major cause of morbidity in
older people, particularly in those who live in residential
and nursing homes (RNHs). Up to 40% of RNH resi-
dents are depressed [1,2]. The annual incidence of
depression is around 12%, with depression resolving
after a year in only about half of cases [3]. In many
cases the depression is not recognized by the RNH staff
or by the resident’s general practitioner [4,5].
There is a move away from drug treatment for mild/
moderate depression. Guidelines from the UK National
Institute of Health and Clinical Excellence (NICE) do
not recommend drug treatment for mild depression and
suggest that drugs should be used only as part of a
more holistic package of care for those with moderate
depression [5]. The conventional medical approach of
opportunistic diagnosis and drug treatment is insuffi-
cient to address depression in this population because of
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poor recognition, low intervention rates and the toxicity
of medications. In care homes tricyclic agents appeared
effective but poorly tolerated [4], whilst more modern
drugs are well tolerated but are less well researched in
this setting [6,7]. The use of drugs as the primary
approach to managing depression in these patients pre-
sents three problems: the failure to recognise mild/mod-
erate depression, the absence of evidence of effectiveness
in the very elderly (aged > 80), [8] and the potential for
serious adverse events, in particular amongst those on
multiple medications. Typically RNH residents are on
6-8 different drugs, with most receiving at least one psy-
chotropic agent [1,9]. Conditions such as cardiac disease,
diabetes, and renal impairment that are likely to require
caution in prescribing antidepressants among older peo-
ple are highly prevalent in RNH residents (32%, 20% &
4% respectively) [10]. Falls are a major cause of morbidity
and mortality in older people and antidepressant drugs;
both tricyclics and SSRIs are associated with a two-fold
increase in falls in care home residents [11].
Multiple physical morbidities are expected in RNH
residents [12] and lack of social interaction has been
shown to be common in observational research in resi-
dential settings [3]. There is good evidence that both
functional impairment and loneliness are risk factors for
depression in RNH residents [12]. There is a growing
recognition that addressing single outcomes such as
falls, cardiovascular disease or depression as isolated
problems inadequately addresses the needs of this group
[13]. Depression is a viable target for public health inter-
ventions as physical health and costs of care are signifi-
cantly higher for older people with depression [14,15].
Exercise is a promising non-medical approach to the
management of depression. Plausible mechanisms for its
possible effect include improved social contact, a diver-
sion from negative thoughts, and the physiological
effects on neurotransmitters such as monoamines &
endorphins [16]. Experimental evidence also supports
progressive strength training as a method of reducing
depression [17].
A number of systematic reviews which pooled data
from different study designs found that exercise
improved depression [15,18]. A review of 14 randomised
controlled trials suggested that exercise might be effica-
cious in reducing symptoms of depression in the short
term, although all of these studies had significant limita-
tions. No statistically significant differences were found
between aerobic and anaerobic exercise regimens [15].
NICE guidelines recommend exercise as a first line treat-
ment for mild depression [19]. A systematic review of the
effects of exercise on depression in older people con-
cluded that it might be efficient at reducing depressive
symptoms in the short term but that there were insuffi-
cient data on its long-term effect [18]. Interventions were
of short duration, the trials were small, none were in
RNH settings and none sought to change participants’
approach to exercise throughout the week [18].
Maximising psychological and physiological effects
from an exercise regimen requires that increased exer-
cise is built into residents’ usual routine. However active
residents may be during brief formal exercise sessions,
these will occupy only a small percentage of their time.
Engineering a system change within RNHs so that
increased exercise is both facilitated and actively encour-
aged will ensure that residents are regularly exposed to
the intervention throughout the week. In this trial we
are testing a pragmatic intervention, reflective of current
best practice, consisting of training for RNH staff to
support the building of safe physical activity into the
RNHs’ normal routine; and a twice-weekly formal exer-
cise class led by a specially trained physiotherapist. This
is a ‘whole RNH’ intervention; all residents without an
absolute contraindication to exercise will be invited to
attend the class and to increase physical activity gener-
ally. This allows depressed residents to benefit from
interaction with non-depressed residents; and reflects
how such a programme, if effective, might be implemen-
ted in RNHs by physiotherapists. Furthermore, it may:
avoid the use of drug treatment; demedicalise mild/
moderate depression; confer wider health benefits;
improve social interactions within RNHs; and have ben-
eficial effects on all residents.
The protocol reported here was developed for an NHS
Health Technology Assessment (HTA) funded trial and
amended after a pilot study to test the procedures [20].
A process evaluation was commissioned to run along-
side this trial and is reported separately [21].
Methods
Research aim
To establish the impact of a ‘whole home’ intervention,
consisting of training for residential and nursing home
staff combined with twice-weekly evidence based, phy-
siotherapist-led exercise class, on the prevalence of
depression amongst residents.
Trial design
This is a cluster-randomised trial with the RNH as the
unit of randomisation and residents as the unit of
assessment to measure the impact of a whole RNH
intervention to increase exercise on the prevalence of
depression and the remission of existing depression. To
reduce NHS treatment costs we are using an unbalanced
randomisation:- 1 intervention home:1.5 control homes.
Sample size
The original brief from the NHS HTA programme spe-
cified the outcome as rate of remission in those
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depressed at baseline. We estimated that we needed to
recruit 77 RNHs and at least 418 residents with depres-
sion at baseline to detect an increase in remission rates
from 25% to 40%. Our primary analysis will be a com-
parison of the difference in proportion of depressed resi-
dents at the end of the study (40% v 25%). Recruiting
participants from 77 RNHs gives more than 97% power
to detect this at the 5% significance level, even if we
need to exclude residents recruited post-randomisation
from this comparison. Our sample size estimate includes
an inflation factor to account for clustering effects. Few
previous studies are available to allow us to estimate the
range of likely values for the intra-cluster correlation
(ICC) needed to estimate this. We therefore used a con-
servative value of 0.05 for this, which towards the upper
end of the range seen in previous primary care studies.
This should provide have sufficient power to allow for
likely variation in cluster sizes and for likely clustering
effects due to different physiotherapists carrying out the
exercise programme in different RNHs.
Our calculations also allow for anticipated loss to fol-
low-up. Because few RNH residents move out of resi-
dential accommodation we anticipate good follow-up
rates. This population has a high mortality, up to 34%
per year; additionally, for some, their health will deterio-
rate so that they are no longer able to complete some, if
not all, of the follow-up assessments. However, those
residents with the poorest health are less likely to join
the study, so that we can anticipate a smaller attrition
rate. The nearest equivalent study collected data on
169/220 depressed residents after 9.5 months (77%)
[22], equivalent to 71% at one year. We therefore antici-
pate a loss to follow-up rate of 30%, made up of those
who have died and those no longer willing or able to
complete the assessments.
Homes and Participants recruitment
Recruitment of both the home and residents within the
home at recruitment takes place prior to randomisation
of the RNH to the intervention or control arm. We are
recruiting roughly equal numbers of RNHs in two local-
ities, North East London and the West Midlands. These
two localities have diverse populations that are represen-
tative of the social and ethnic mix of the UK as a whole.
We are seeking to recruit RNHs with a range of charac-
teristics (large/small, independent/chain, local authority/
private/charitable, purpose-built/traditional, nursing/resi-
dential). One pilot home and one home recruited early in
the study were dementia specialist homes, but we found
that the proportion of residents able to complete the
questions for our primary outcome measure (the geriatric
depression scale - 15 item version) was small and con-
cluded that recruiting such homes was not the best use
of our resources for recruitment and intervention
Eligibility Criteria
We have set our entry criteria for our assessments as
wide as possible to ensure generalisability of our results.
The study is open to any older person living in a resi-
dential or nursing home who is able to communicate
and is fit enough to participate in the assessments
(Table 1). To contribute to our depression outcomes
participants need to be able to provide GDS-15 data.
Recruiting Participants
We consider for inclusion all permanent residents in
RNHs, unless staff of the RNH identify a resident as
inappropriate to approach for consent/assent either
directly or via their next of kin, for example those with
a very limited life expectancy. A specially trained health
professional briefly assesses each individual to explain
the study, to assess his/her competence to give consent
and to participate in the research assessments,
and assess where he/she meets the inclusion criteria
(Table 1). Residents are given information about the
study in a suitable format (e.g. large print or audio). The
staff of the RNH together with research nurse identify
residents who are unable to participate in any assess-
ments but who nevertheless may be able to give consent
to the use of their routine data. This group might
include those unable for any reason to communicate in
English sufficiently well to participate in the assess-
ments. Competent residents have the opportunity to
reflect on whether they wish to join the study prior to
giving consent to the assessments and/or the use of
their medical records. The next of kin of those deemed
not competent to consent to the study assessments are
approached for their assent for the resident to take part
in the assessments and/or the use of their medical
records. We repeat the recruitment procedure for any
new permanent residents in participating RHNs up to
nine months following that RNH’s randomisation.
Baseline assessments and data collection
Baseline assessments, lasting around 30-60 minutes, are
carried out by a research nurse and take place after con-
sent/assent has been obtained and before randomisation.
At this assessment, we confirm eligibility, administer the
Table 1 Inclusion and exclusion criteria
Inclusion Criteria Exclusion criteria
Assessments
Permanent resident in RNH Problems communicating by any means
Aged 65 or over Terminal or other serious illness
Consent/assent to
assessment
Non-English speakers for who a
translator is not available
Able to participate in
baseline assessment
Consent/assent to record examination
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questionnaire instruments (GDS-15, EuroQol, MMSE,
fear of falling, current pain) and a brief physical assess-
ment, the Short Physical Performance Battery (SPPB).
We collect demographic data (age, sex, ethnicity, social
class and age left school) and data on length of resi-
dence, fee status and current medication from the RNH
records for all those for whom we have consent/assent
to access their records. We collect data for the Barthel
Index, social engagement scale, and proxy values for the
EQ-5D from the care staff.
The diagnosis of depression is commonly overlooked
in RNH residents [22]. It would be inappropriate, once
we have identified depression, to prevent these residents
from accessing appropriate health care, so we provide
the RNH staff with participants’ Geriatric Depression
Score (GDS-15) scores, and an interpretation of their
meaning. If the GDS score is 10 or more we encourage
the home to discuss this result with the resident’s gen-
eral practitioner.
Data management
All data are managed in line with Warwick Clinical
Trial Unit’s standard operating procedures.
Randomisation
For each location, we minimise by size and type of
home. Homes are categorized by size and by a combina-
tion of ownership (for profit/charitable/local authority, )
and services offered (residential/nursing/both). A statis-
tician separate from the rest of the study team is
responsible for generating the homes’ random allocation
using a computerised minimisation program.
A particular problem for cluster randomised trial can
be the need to recruit participants after the cluster has
been randomised. For our primary outcome, prevalence
of depression one year after randomisation may be
affected by this since we are including participants who
moved into the homes following randomisation. For
these residents randomisation allocation concealment is
impossible because all RNH staff and study staff visiting
the RNHs are aware of the home’s allocation [23,24].
We ensure that we are aware of all new residents and
monitor reasons for exclusion from the study. For our
secondary outcomes related to improvement in depres-
sive symptoms we only include participants resident in
the homes at the start of the study. All of their baseline
data are collected prior to randomisation to ensure that
for this analysis we can achieve allocation concealment.
Interventions
Control Intervention
In line with the MRC’s Good Clinical Practice Guide-
lines there is an active control intervention in all partici-
pating RNHs to ensure that they are aware of current
best care for the identification and management of
depression in this population. This intervention consists
of depression awareness training for staff in the RNH.
By using current best care as our control, we can ensure
that any benefits identified are due specifically to our
intervention package rather than to raising awareness of
depression within the intervention RNHs. This interven-
tion reduces the risk of ‘resentful demoralisation’ in the
control homes affecting recruitment of new residents
after randomisation or even leading to the RNH with-
drawing from the study [25].
The depression awareness programme consists of brief
(around 45-60 minutes) training backed up with a spe-
cially created DVD on recognizing depression and infor-
mation leaflets and posters. In addition we inform the
staff of all RNHs of the GDS-15 scores of all participat-
ing residents. In the control homes our research nurses
will deliver this intervention soon after randomisation.
In the active intervention RNHs the depression aware-
ness training will be delivered by the research phy-
siotherapists as part of the overall intervention package.
More details of the control intervention package are
available on request from the research team.
Active intervention
We aim to test a pragmatic intervention, which could be
implemented as part of routine health/social care. This
is a ‘whole-home’ intervention aiming to change the
culture of the home to increase promotion of
physical activity. The intervention includes a physical
activation programme, supported by a twice-weekly
physiotherapist-led exercise class. The intervention will
continue for one year in each home. We anticipate that
our intervention, as well as improving mood should also
improve functional abilities, reduce falls, and improve
mobility.
Several studies have found that low intensity and
poorly implemented physical activation programmes may
increase falling [26,27] and pose a threat to the safety of
older people living in nursing homes. We consider it
essential to the safety of participants that experienced
therapists implement the intervention. They need to have
the essential awareness of the multiple health problems
facing older people in care settings, of exercise prescrip-
tion in frail older adults, and of promoting safe mobility.
Therapists attend a two-day course to be trained in the
intervention. The intervention is documented and standar-
dised, but allows therapists a range of options to adapt the
content to the needs of the groups/settings. This approach
has been successful in previous studies we have conducted
with physiotherapists; therapists are happy that the
approach reflects their practice and, importantly, it is pos-
sible to document the concept and method with the preci-
sion necessary for replication and dissemination [28]. This
approach utilises recognised methods of selecting baseline
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exercise intensity, and progressing exercise [17] modified
for frail older people. Exercise that utilises rhythmic move-
ment and reflex motor activation is effective in people
with cognitive impairment [29]. The intervention seeks to
minimise unwanted side-effects including an increase in
falls and pain.
The physical activation programme promotes a com-
mitment to encouraging safe physical activity for resi-
dents of the home. Evidence suggest that for a complex
intervention of this nature to be effective it needs to be
‘normalised’; that is, it should be seen as part of the
organisation’s normal functioning rather than as an
optional extra [30]. If a positive approach to increasing
exercise in the residents is built into the values of RNH
staff, the likelihood of an exercise intervention having a
positive effect will be maximised. The main activity that
is targeted in the physical activation programme is safe
walking, which is a realistic aim [31].
A growing body of evidence on diffusion of innovation
and implementation of guidelines into clinical practice has
highlighted organisational context as a key factor in effect-
ing change in practice [32,33]. Successful implementation
is more likely if the intervention/guideline resonates with
the experience of those being asked to embrace it [32,34]
Embedding the exercise intervention within a whole-home
strategy that actively engages with the organisational con-
text in which the intervention is delivered should enhance
the effectiveness of implementation.
The physiotherapists:
1. Improve knowledge and awareness of the benefits
of physical activity in the staff, residents and
relatives.
2. Provide an individualised review of mobility safety.
3. Ensure that appropriate and safe walking aids
(including grab rails where needed), and footwear
are available to each individual, and reinforce the
need for use [35].
4. Provide advice on activation strategies for indivi-
dual clients, including the level/type of assistance/
supervision needed, and support the staff and resi-
dents in their implementation.
5. With the Director of Nursing/Home Manager,
review the policies and strategies in place to pro-
mote physical activity.
6. Where appropriate, involve volunteers and
families in the supervision and promotion of physical
activity.
All residents are invited to attend twice-weekly group-
based exercise classes in the communal space of the
homes. All new residents are encouraged to enter the
groups as they enter the home. An exercise intervention
as part of routine care in a residential setting should be
available to all residents, not just those with diagnosed
depression. This is both for the practical reason that it
removes the requirement to formally to identify those
entitled to attend and also because such an intervention
it is less likely to be effective if only those who are
depressed attend.
The groups are led by physiotherapists experienced in
managing frail older people.The sessions use mixed
training stimuli, combining aerobic conditioning, pro-
gressive strength and balance training. The programme
utilises music and rhythmic, simple movement patterns.
The groups have around 12 to 15 participants, and last
40 minutes to an hour depending on the tolerance and
ability of the group. Prior to the groups, the phy-
siotherapists give each participant a brief risk assess-
ment; determining any absolute contra-indications to
exercise, and the optimal exercise intensity for each par-
ticipant. The physiotherapist may have a group with a
range of abilities, and thus intensity is set to ensure
safety of all participants. In larger homes, where there
may be a need for several groups, physiotherapists
group together participants with similar levels of ability,
and set the intensity of exercise accordingly. It is chal-
lenging to gain engagement and attendance from
depressed individuals, but maximising participation is
essential to demonstrating effectiveness of the technol-
ogy. Consent/assent to study assessments does not indi-
cate consent to participate in the exercise class on any
particular day. We comply with best clinical practice for
consent to physiotherapy treatment to obtain agreement
from individuals for participation in the exercise class.
The physiotherapists work with staff to gain participants’
trust and acceptance of the programme.
Follow-up
Follow-up assessments for all consenting/assented resi-
dents take place six months and one year after the
home is randomised. Data from medical records are col-
lected 3-monthly. If any residents have moved to
another RNH in the locality when their assessments are
due, we endeavour to carry out their assessments in
these alternative locations.
Outcome measures
The primary outcome measure is the geriatric depres-
sion scale 15 (GDS-15) [36]. This brief scale/score con-
sists of 15 simple yes/no questions and has been well
validated in residential situations. It avoids using poten-
tially somatic features of depression which may be mis-
leading in this age group, focusing more on mood and
functional symptoms of depression[37]. It is one of the
most widely used measures in this field. It is simple to
complete, with 97% of cognitively intact nursing home
residents producing analysable data, and it has good
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internal consistency in this population, and a score of
five or above appears to give the best sensitivity and
specificity [36-38]. The GDS-15 has also been used as a
continuous measure in at least one RCT based in a nur-
sing home[39].
All residents will be exposed to the intervention and
any positive or negative effects may impact both those
who are depressed and those who are not depressed.
We will therefore measure outcomes in all participants.
With a long term (one year) intervention we expect the
effects to accrue, and for this reason our primary out-
come is depression in residents at one year follow-up.
Because we expect some change in the population dur-
ing the year due to deaths and other movements out of
the homes, we have chosen to base our primary out-
come on residents in the home at twelve months, rather
than those residents at baseline.
We had also planned to collect data at six months on
those participants with depressive symptoms GDS-15 ≥5
at baseline. During the first few months of recruitment
the average cluster size was smaller than originally
anticipated, (around 11 residents per home rather than
16), reducing our statistical power. With the agreement
of the independent Trial Steering Committee we chan-
ged to collecting data on all participants at six months
allowing us to also test the mean change in number of
depressive symptoms. We selected six months because if
exercise were an effective treatment for depression we
would expect a response in a similar time to that of
drugs. In drug trials we would expect maximal effect to
be seen by four months, but there will be a time lag
between randomisation and any benefits from the exer-
cise programme because of the time taken to start chan-
ging the attitudes of the RNH staff and to establish the
class as a regular routine in the RNH. We estimate that
the intervention is fully functional two months after ran-
domisation; and thus our first assessment is at six
months.
Because we want to understand as much as possible
about how the intervention works in practice and to
explore any barriers to implementation we have
included a number of secondary outcome measures:
Depression
Change in severity of depressive symptoms in depressed
residents (GDS-15) and proportion of residents
depressed at baseline that experience remission from
that depression (GDS-15).
Cognition
Mini-mental State examination (MMSE) [40]. This scale
allows a reliable assessment of degree of cognitive
impairment. Sensitive to change and reliable in multiple
care settings, it is the most commonly used scale to
assess degree of cognitive impairment.
Health-related quality of life
EuroQol is a 5-item generic scale with a validated health
utility index for calculation of QALYs (Quality Adjusted
Life Years) [41]. It has been successfully used in care
home populations [42].
Physical function
To assess the effect of the programme on mobility we
will use the Short Physical Performance Battery (SPPB),
which incorporates three essential aspects of mobility
that should be improved by the exercise programme;
balance, chair rise and walking ability. The SPPB has
been used extensively in trials and observational studies
of older people. Because of the central importance of
physical function to the ability to thrive, has well estab-
lished and surprisingly strong relationships with a range
of important public health outcomes, including onset
and progression of disability; mortality and nursing
home admission [43,44].
Chronic Pain
We will ask participants to rate their current level of
pain, i.e. pain today, on a five-point numerical rating
scale at each follow-up
Fear of falling
We will ask participants about their fear of falling (yes/
no); this is an independent predictor of falls risk [45].
Mortality
We will arrange for the records of all those from whom
we obtain consent/assent to examine their records to be
flagged at NHS central registry.
Hospital admissions
We will extract data on cause and duration of any hos-
pital admissions during the study period from partici-
pants’ hospital records.
Peripheral fractures
Rather than measuring falls, most of which do not cause
injury, we will measure the rate of peripheral fractures
as a marker for injurious falls. We will identify these
from the RNH and hospital records.
Medication use
We will estimate participants’ medication use over the
follow-up period using data on their regular medications
collected at baseline and subsequent time points. We
will use these data to estimate their total use of medica-
tion over the study period.
Cost-effectiveness
We will assess the cost-effectiveness of the exercise pro-
gramme from both a societal and an NHS perspective.
Statistical analysis
We will compare the characteristics of RNHs (location,
type and size of home) and individuals (age, sex, baseline
assessment scores) in our intervention and control arms
using simple descriptive statistics. We will summarise
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outcome measures by RNH and, in the intervention arm,
physiotherapist, and use computer software that can
measure the extent of clustering at two levels to estimate
clustering parameters.
To assess the difference in proportions depressed at
12 months between intervention and control homes we
will initially use generalised estimating equations (to
account for clustering by RNH) with a logit link (to
allow for a binary outcome) in Stata. For other out-
comes we will use different link functions as appropri-
ate. We will include covariates in our analysis. Ideally
these should be chosen on the basis of predictive value.
As far as possible we will assess evidence from the pre-
vious literature to identify potential covariates. However,
the strategy of choosing covariates based on predictive
value arises from work pertaining to individually rando-
mised trials and application to cluster randomised trials
is more complicated, particularly for individual level
covariates and binary outcomes [46,47]. In addition, the
previous literature from which we can identify cluster-
level covariates is not extensive. We therefore propose
the following strategies for covariate identification:
For our primary outcome, the proportion of residents
depressed at the end of the study, we will consider the
following cluster-level variables for incorporation as cov-
ariates in our models:
• Location of home (our stratification variable).
• Measurable characteristics of care homes and resi-
dents identified from previous literature as related to
the prevalence of depression;
• Baseline level of depression in care home (based
on empirical evidence that baseline levels of out-
come are often important covariates);
• Other measurable characteristics of care homes or
residents within care homes hypothesised by the
study team as being related to outcome.
The covariates to be included will be finalised in a sta-
tistical analysis plan prior to analysts becoming un-
blinded to randomisation group.
For other outcomes: change in severity of depression
for those depressed at baseline, remission rate and geria-
tric depression score-15 score we will use a similar
strategy, but for these outcomes measurements at base-
line and outcome will be of the same individual. We
will therefore introduce baseline levels of depression
severity as covariates at the individual, rather than the
cluster, level.
If our preliminary analyses indicate the presence of
additional clustering by physiotherapist, we will need to
incorporate this in our analyses of outcomes. This will
be done using WinBUGs software which allows the
building of flexible mixed-effect models such as that
needed to incorporate clustering by physiotherapist,
which if it exists, will exist in only one arm of our trial.
Health economic analysis
Our primary analysis will be a cost utility analysis exam-
ining the cost per quality adjusted life year gained for all
those residents we have assessed. We will not have
health utility data on those who did not participate in
the assessments. These residents will also have been
exposed to the intervention. We will therefore do a sec-
ondary costs and consequences analysis to assess the
impact of our programme on the prescribing and other
health care costs for all residents where we have con-
sent/assent to examine their records. The costs of the
exercise programme to RNHs, in terms of time taken to
set up and monitor the exercise routines, or to imple-
ment the control intervention, will be estimated from
data provided by participating RNHs. Other important
resource units to capture are prescription costs; GP and,
for residential homes, community nurse consultations;
attendance at hospital A&E and outpatients; and hospi-
tal bed-days. These health service usage data will be col-
lected from RNH and hospital medical records. We will
use the EuroQol to calculate health utility for our cost-
utility analysis.
Ethical considerations
This study is a complex intervention within a cluster-
randomised trial involving a potentially vulnerable parti-
cipant population, some of whom will be unable to give
consent. Thus raises a number of ethical issues, includ-
ing consent to cluster randomisation, individual consent
to the exercise component of the intervention, participa-
tion in research assessments and access to records. Spe-
cific measures have been incorporated into the study to
address these issues, drawing on recommendations for
good practice as well as legal and regulatory frameworks
[46,48-50]. To ensure compliance with Mental Capacity
Act 2005 sections 3, 30-34 we seek next of kin assent
for those residents not competent to consent[51]. The
process evaluation study for this project includes obser-
vation of the consent process and exploration of resi-
dents and next of kin views on this.
To explore issues of consent further we will, hold two
focus groups to explore the views of key informants in
the wider community (representatives from local and
national user groups) about carrying out this study in
nursing and residential homes and the process of con-
sent for such research. This will inform ethical analysis
of our approach to recruitment and consent.
The Joint University College London/University Col-
lege London Hospital Committees on the Ethics of
Human Research. Reference number 07/Q0505/56 pro-
vided ethical review for the study
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Adverse Event Monitoring
We have prepared a protocol for monitoring and report-
ing adverse events. The protocol covers the specific
requirements for recording and reporting adverse events
in a cluster randomised trial where adverse events are
expected to be high due to the age and frailty of the
participants. The protocol distinguishes between adverse
events that are directly attributable to the study inter-
ventions, and the monitoring of peripheral fractures and
deaths indirectly attributable to the study. The trial has
a Data Monitoring and Ethics Committee
Discussion
At the time of writing, April 2010, over 70 homes have
been randomized with an average number of residents
providing GDS-15 data of around 11 per home. It is
anticipated that recruitment will be completed in May
2010. Follow up will be completed one year later and
the results available late 2011. Although it is not possi-
ble to comment on the effectiveness of the intervention
it is evident that both interventions are well received
within the homes and the exercise groups are popular
with the residents.
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